Halozyme to Report Second Quarter 2026 Financial and Operating Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 108.31 -1.55 (1.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $109.86 | 52 Week High | $18.39 | |||
| Open | $109.62 | 52 Week Low | $6.96 | |||
| Day High | $109.87 | P/E | N/A | |||
| Day Low | $107.68 | EPS | $-0.58 | |||
| Volume | 1,856,186 | |||||
